02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

326 LEVOCETIRIZINE<br />

LEVOCETIRIZINE<br />

Trade names: Vozet; Xozal; Xusal; Xyzal (UCB Pharma)<br />

Indications: Allergic rhinitis, chronic idiopathic urticaria<br />

Category: Antihistamine<br />

Half-life: 6–10 hours<br />

Clinically important, potentially hazardous interactions<br />

with: N/A<br />

Reactions<br />

Skin<br />

Dermatitis<br />

(2006): Cusano F+, Dermatology 213(4), 353<br />

Fixed eruption<br />

(2005): Guptha SD+, Indian J Dermatol Venereol Leprol 71(5), 361<br />

(2005): Mahajan VK+, Int J Dermatol 44(9), 796<br />

Pruritus<br />

Rash (SIC)<br />

Urticaria<br />

(2005): Kranke B+, Dermatology 210(3), 246<br />

Mucosal<br />

Xerostomia (3%)<br />

Other<br />

Abdominal pain<br />

Anaphylactoid reactions/Anaphylaxis<br />

Cough<br />

Fever<br />

Hypersensitivity<br />

Myalgia/Myositis/Myopathy/Myotoxicity<br />

Weight gain (0.5%)<br />

LEVODOPA<br />

Synonym: L-dopa<br />

Trade names: Brocadopa; Dopaflex; Doparl; Eldopal;<br />

Levodopa-Woelm; Sinemet (Bristol-Myers Squibb)<br />

Indications: Parkinsonism<br />

Category: Dopamine precursor<br />

Half-life: 1–3 hours<br />

Clinically important, potentially hazardous interactions<br />

with: kava, MAO inhibitors, phenelzine, pyridoxine, selegiline,<br />

tranylcypromine<br />

Sinemet is carbidopa <strong>and</strong> levodopa<br />

Reactions<br />

Skin<br />

Chromhidrosis (1–10%)<br />

Diaphoresis<br />

(1995): Sage JI+, Ann Neurol 37, 120<br />

Exanthems<br />

Hypomelanosis guttata<br />

(2001): Mocci A, Panama City, Panama (from Internet)<br />

(observation)<br />

Lupus erythematosus<br />

(1985): Stratton MA, Clin Pharm 4, 657<br />

Melanoma<br />

(2002): Wobbes T+, Ned Tijdschr Geneeskd 146(27), 1286<br />

(1997): Pfützner W+, JAmAcadDermatol37, 332<br />

(1996): Kleinhans M+, Hautarzt (German) 47, 432<br />

(1993): Weiner WJ+, Neurology 43, 674<br />

(1992): Haider SA+, Br J Ophthalmol 76, 246<br />

(1992): S<strong>and</strong>yk R, Int J Neurosci 63, 137<br />

(1989): K<strong>and</strong>e’l EI, Zh Nevropatol Psikhiatr (Russian) 89, 126<br />

(1987): Morpurgo G+, Eur J Cancer Clin Oncol 23, 1213<br />

(1985): Kochar AS, Am J Med 79, 119<br />

(1985): Przybilla B+, Acta Derm Venereol (Stockh) 65, 556<br />

(1985): Rampen FHJ, J Neurol Neurosurg Psychiatry 48, 585<br />

(1984): Abramson DH+, JAMA 252, 1011<br />

(1984): Rosin MA+, Cutis 33, 572<br />

(1982): Van Rens GH+, Ophthalmology 89, 1464<br />

(1980): Bernstein JE+, Arch Dermatol 116, 1041<br />

(1980): Warner TF+, JCutanPathol7, 50<br />

Pemphigus<br />

(1986): Pisani M+, G Ital Dermatol Venereol (Italian) 121, 39<br />

Purpura<br />

Rash (sic)<br />

(1984): Goetz CG, Clin Neuropharmacol 7, 107<br />

(1983): Goetz CG, NEnglJMed309, 1387<br />

Urticaria<br />

Vitiligo<br />

(1999): Sabate M+, Ann Pharmacother 33, 1228 (with tolcapone)<br />

Mucosal<br />

Glossopyrosis<br />

Leukoplakia<br />

Sialorrhea<br />

Xerostomia (1–10%)<br />

Hair<br />

Hair – alopecia<br />

Hair – pigmentation<br />

(1989): Reynolds NJ+, Clin Exp Dermatol 14, 317<br />

Nails<br />

Nails – growth<br />

(1984): Danial CR+, JAmAcadDermatol10, 250<br />

Other<br />

Hot flashes<br />

Phlebitis<br />

LEVOFLOXACIN<br />

Trade names: Levaquin (Ortho-McNeil); Quixin (Johnson &<br />

Johnson)<br />

Indications: Various infections caused by susceptible organisms<br />

Category: Antibiotic, quinolone<br />

Half-life: 6–8 hours<br />

Clinically important, potentially hazardous interactions<br />

with: zinc<br />

Reactions<br />

Skin<br />

Acute generalized exanthematous pustulosis<br />

(2005): Corral de la Calle M+, Br J Dermatol 152(5), 1076<br />

Diaphoresis (0.1%)<br />

Edema (0.1%)<br />

Erythema<br />

(2002): Famularo G+, Ann Pharmacother 36(9), 1380<br />

(1992): Kanzaki H+, Jpn J Antibiot (Japanese) 45, 576<br />

Erythema multiforme<br />

Erythema nodosum (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!